Sociocultural issues in clinical research: unraveling the Tuskegee syphilis study.

R. White

DOI: https://doi.org/10.1002/ART.10516

2002-08-15

Arthritis & Rheumatism

Abstract:

What problem does this paper attempt to address?

Infections in VLBW infants: studies from the NICHD Neonatal Research Network.

B. Stoll,N. Hansen

DOI: https://doi.org/10.1016/S0146-0005(03)00046-6

IF: 3.311

2003-08-01

Seminars in Perinatology

Abstract:
Clinical and Pathological Features of Head and Neck Follicular Dendritic Cell Sarcoma.

Ji Li,Min-Li Zhou,Shui-Hong Zhou

DOI: https://doi.org/10.1179/1607845415y.0000000008

IF: 2.264

2015-01-01

Hematology

Abstract:OBJECTIVES:Follicular dendritic cell sarcoma (FDCS) in the head and neck is uncommon. The etiology, pathogenesis, optimal treatment, and prognosis are not well understood. In this review, we investigated these features to deepen the understanding of the disease.METHODS:We reviewed FDCS in the head and neck in the English language literature through Medline. We analyzed the clinical characteristics, pathologic features, immunophenotypic profile, and treatments of FDCS.RESULTS:Of 137 reported cases of FDCS in the head and neck region, 127 included data on age and gender. Among those, 64 were females and 63 were males. The mean age was 46 years (9-79 years). In the 106 cases with complete follow-up data, fourteen patients (13.2%) had local recurrence. Fourteen patients (13.2%) had distant metastasis. The metastatic site involved the lung, liver, adrenal, rib, vertebral body, and iliac bone. The overall 5-year survival rate was 80.0%. Compared to nodal FDCS and extranodal FDCS, the overall 5-year survival rates were 71.1 and 85.3%, respectively, with no significance (P = 0.42), 0.8% waived treatment, 46.6% received surgery alone, 30.5% received surgery combined with postoperative radiotherapy, 8.4% received surgery combined with postoperative radiotherapy and chemotherapy, 7.6% received surgery combined with postoperative chemotherapy, 3.1% received chemotherapy alone, 2.2% received chemotherapy combined with radiotherapy, 0.8% received radiotherapy alone.CONCLUSIONS:FDCS in the head and neck is rare. There was no difference in the survival between nodal and extranodal FDCS. The optimal treatment was undetermined.
Pediatric Sporadic Burkitt Lymphoma of the Head and Neck: A Case Series and Analysis of National Trends

Brett A. Campbell,Gabrielle French,Tieqi Sun,Farrukh Virani,Michael J. Cunningham,Eelam Adil,A. Eliot Shearer

DOI: https://doi.org/10.1016/j.ijporl.2024.112137

IF: 1.626

2024-10-19

International Journal of Pediatric Otorhinolaryngology

Abstract:Objective Burkitt lymphoma (BL) is an aggressive form of non-Hodgkin lymphoma with the sporadic subtype being predominant in North America. The clinical presentations and outcomes of pediatric BL within the head and neck were assessed using both an institutional case series and the Surveillance, Epidemiology, and End Results (SEER) Cancer database. Methods The electronic medical record at our quaternary children's hospital was queried over a 22-year period (2000-2022) for BL patients with head and neck manifestations. Demographics, clinical presentation, staging, treatment, and outcomes data were collected and analyzed. A corresponding review of the SEER database from 1975-2022 was also performed. Results Our institutional case series identified 48 sporadic BL patients with a mean age of 8.7 years, the majority of whom were male (79%) and white (74%). The most common primary sites were the cervical lymph nodes (38%) and (or) palatine tonsils (23%). Thirty-five patients (73%) were treated initially for a presumed inflammatory or infectious process before undergoing malignancy work-up, which did not significantly delay time to diagnosis (31.5 vs. 38.8 days, p= 0.27). The SEER database analysis identified 78 cases, 43.5% of whom were 5 to 9 years of age, with a similar male (66%) and Caucasian (76.9%) predominance. Cervical lymph nodes were also the most common subsite (67%), followed by the palatine tonsils (13%). Remission rates were similar, 93.7% and 94.8%, respectively, in both the institutional and SEER database cohorts. Conclusion Unilateral cervical lymphadenopathy and asymmetric tonsillar hypertrophy are the most common presentations in sporadic BL in the head and neck. Clinical presentation in patients with BL is often similar to common, insidious pediatric otolaryngology symptoms and a majority of patients initially undergo treatment for presumed infectious or inflammatory disease. Although overall BL disease-free survival is high even for disseminated BL, the prognosis is better for local/regional disease, and minimizing time to diagnosis and treatment should remain a priority.

pediatrics,otorhinolaryngology
Head and neck carcinoma in children: A clinicopathological study of 42 cases

Xin-Jia Cai,Zu-Nan Tang,Yu-Ping Liu,Xu Wang,Jia-Ying Bai,Xiao-Wen Guo,He-Yu Zhang,Jian-Yun Zhang,Tie-Jun Li

DOI: https://doi.org/10.1016/j.jds.2023.04.027

IF: 3.719

2023-05-01

Journal of Dental Sciences

Abstract:Background/purpose Cancer is an important part of the global burden of childhood diseases. Head and neck carcinoma in children is rare and related research is limited. This study aimed to investigate the clinicopathological features of childhood head and neck carcinoma. Materials and methods Forty-two cases of childhood head and neck carcinoma treated in our institution were reviewed and analyzed. Results Median age overall was 11 years. Twenty-three patients (54.8%) were male and 19 (45.2%) were female. Parotid gland location was most common (54.8%). Mucoepidermoid carcinoma and squamous cell carcinoma were the most common histological types (57.1% and 11.9%, respectively). Two patients had a history of bone marrow transplantation and two had a history of odontogenic keratocyst. The recurrence rate after treatment was 8.6%. Conclusion Early diagnosis and treatment and close follow-up of childhood head and neck carcinoma are warranted to prevent recurrence and improve clinical outcome.

dentistry, oral surgery & medicine
Pediatric mandibular malignancies: a comprehensive analysis of SEER data

S.L. Newman,N.B. Drury,K.T. Lee,A.K. Devarakonda,A. Ahmed,H.K. Koehn

DOI: https://doi.org/10.1016/j.ijom.2024.08.002

IF: 2.986

2024-08-18

International Journal of Oral and Maxillofacial Surgery

Abstract:Mandibular malignancies are rare in the pediatric population and subsequently not well characterized. SEER 18 registry data was collected, applying age 0–18 years and ICD-O-3 code C41.1 ('mandible'). Univariate Cox regression analysis was conducted, and hazard ratios (HR) were calculated for overall survival (OS) and disease-specific survival (DSS) according to patient demographics, tumor characteristics, and treatment. Kaplan–Meier survival curves were generated for OS and DSS. Sixty-four patients met the inclusion criteria. The median age at diagnosis was 13.0 years, and median survival was 8.7 years. Osteosarcoma was the most common histological diagnosis ( n = 22). Sex, race, age (<13 vs ≥13 years), histological type, odontogenic origin, and treatment modality were found not to be associated with OS or DSS. The SEER stage 'distant' was significantly associated with an elevated HR of 6.28 for DSS ( P = 0.027) and 5.29 for OS ( P = 0.025). Kaplan–Meier survival curves demonstrated significantly lower 5-year DSS ( P <0.001) and OS ( P <0.001) for SEER 'distant' stage. This study includes the analysis of a large number of pediatric mandibular malignancies when compared to previous studies. 'Distant' stage was associated with decreased survival. Early clinical suspicion and diagnosis are paramount for improved survival.

dentistry, oral surgery & medicine,surgery
Epidemiology, Risk Factors, and Prevention of Head and Neck Squamous Cell Carcinoma

Adam Barsouk,John Sukumar Aluru,Prashanth Rawla,Kalyan Saginala,Alexander Barsouk

DOI: https://doi.org/10.3390/medsci11020042

2023-06-14

Medical Sciences

Abstract:Head and neck squamous cell carcinoma (HNSCC) is a group of malignancies, involving the oral cavity, pharynx, hypopharynx, larynx, nasal cavity, and salivary glands, that together compose the seventh most common cancer diagnosis worldwide. With 890,000 new cases and 450,000 deaths annually per GLOBOCAN estimates, HNSCC accounts for roughly 4.5% of cancer diagnoses and deaths. In the developing world, the incidence of HNSCC is growing with increasing consumption of tobacco (smoked or chewed), alcohol, and areca nut (betel quid). Alcohol and tobacco have a synergistic effect, with the heavy consumption of both increasing HNSCC risk 40-fold. In developed nations, HPV-related HNSCC surpasses tobacco- and alcohol-related disease. HPV-related HNSCC more commonly affects the oropharynx, hypopharynx, and larynx than the oral cavity, and is associated with a significantly longer median survival (130 months vs. 20 months). Discrepancies in etiology as well as disparities in lifestyle choices and access to healthcare may account for the greater incidence and poorer survival of HNSCC among minority and lower-socioeconomic-status communities in developed nations. Pharmacotherapy and counseling together have been shown to be effective in promoting smoking and alcohol cessation. Education on cancer risk and community engagement have reduced areca nut consumption in Asia as well as in diaspora communities. HPV vaccination, starting at age 11–12 for both sexes, has been shown to reduce the prevalence of high-risk HPV serologies and prevent pre-cancerous lesions of the cervix, vagina, and vulva. As of 2020, 58.6% of eligible adolescents in the US have received the full two-vaccine series. Increased adoption of vaccination, education on safe sex practices, and routine visual oral screening for high-risk patients would curb growing HNSCC incidence in developed nations.
Retrospective analysis of clinical features and prognosis of nasopharyngeal carcinoma in children and adolescents

Tianyu Gong,Yupeng Liu,Huiqun Jie,Min Liang,Wenjin Wu,Jingrong Lu

DOI: https://doi.org/10.3389/fped.2022.939435

IF: 3.569

2022-09-17

Frontiers in Pediatrics

Abstract:Objectives: To investigate the clinical characteristics and prognosis of nasopharyngeal carcinoma (NPC) in children and adolescents in different age groups. Materials and methods: The clinical data of 51 patients with NPC aged ≤ 18 years who were treated in Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine from January 2012 to May 2017 were retrospectively analyzed. The patients were divided into children group (≤12 years old) and adolescent group (12–18 years old) with 12 years old as the boundary. The clinical characteristics, diagnosis, treatment, and prognosis of the children and adolescent groups were compared. Results: The symptoms of the first diagnosis in the children group were mainly nasal congestion ( P = 0.043) and ear symptoms ( P = 0.008). The diagnosis rate of nasopharyngeal biopsy in the children group was lower ( P = 0.001), while the rate of diagnosis of cervical mass biopsy was significantly higher than that in the adolescent group ( P = 0.009). The proportion of keratinizing squamous cell carcinoma of the children group was higher than that of the adolescent group ( P = 0.006). There was no significant difference in TNM stage and risk stratification between the two groups, but the number of cases in the III-IVa children group who received induction chemotherapy + concurrent chemoradiotherapy was less than that in the adolescent group ( P = 0.013). The proportion of radiotherapy in the upper and lower cervical lymph node drainage areas was lower than that in the adolescent group ( P = 0.001). The percentage of recurrence and metastasis in the children group was higher than that in the adolescent group ( P = 0.026). Conclusion: The diagnosis in the children group depended on endoscopic biopsy and neck mass biopsy, and the proportion of keratinizing squamous cell carcinoma was higher. The number of cases of induction chemotherapy and concurrent chemoradiotherapy in the children group was less than that in the adolescent group, and the proportion of radiotherapy in the upper and lower cervical lymph node drainage areas was lower than that in the adolescent group. Clinically, it is necessary to improve the understanding of the clinical characteristics of children with NPC and take appropriate treatment strategies.

pediatrics
Squamous cell carcinoma of the head and neck with unknown primary: trends and outcomes from a hospital-based registry

Michael A. Cummings,Sung Jun,Paul Van Der Sloot,Michael T. Milano,Deepinder P. Singh,Anurag K. Singh,Sung Jun Ma

DOI: https://doi.org/10.21037/atm-20-4631

IF: 3.616

2021-02-01

Annals of Translational Medicine

Abstract:BACKGROUND: Squamous cell carcinoma of unknown primary of the head and neck region is a known entity described mainly by retrospective reports. We searched a hospital-based registry to better describe the changing incidence, and to assess diagnostic and treatment strategies.METHODS: The National Comprehensive Cancer Database was queried for head and neck cancers from oropharynx, tonsil, tongue, larynx, hypopharynx primary sites with a designation of clinical T0, representing an unknown primary. Kaplan Meier, Cox multivariate models, and propensity matched cohorts were used to assess significant factors for overall survival.RESULTS: There were 964 cases that met the criteria, and 468 cases with known treatments, staging, and survival data. The incidence increased over time, with the highest rates supported in the last 5 years. In patients who underwent HPV testing, 72% were positive. Patients with AJCC 7<sup>th</sup> clinical N2c or N3 disease had significantly worse outcomes despite the majority receiving neck dissection, radiation, and chemotherapy. Local surgery, compared to incisional or excisional biopsy, had the highest diagnostic yield of finding a primary tumor. In multivariate models, no combination of surgical approach, radiation, or systemic therapy was significantly associated with improved survival. This remained true in 1:1 propensity matched cohorts for age, comorbidities, and clinical nodal burden. In a subset of cN1 patients, combined chemoradiation therapy after excisional biopsy or local surgery was associated with (not statistically significant) improved survival compared to radiation alone (P=0.054).CONCLUSIONS: The incidence of unknown primary head and neck carcinoma is increasing, and current cases have a high proportion of HPV positivity. HPV positivity predicts strongly for a tonsil primary. Local surgery was associated with the highest diagnostic yield. Clinical nodal burden strongly predicts for overall outcome, and type of treatment facility is an important driver of survival. A subset of cN1 patients may benefit from the addition of chemotherapy to radiation.

oncology,medicine, research & experimental
Oral Squamous Cell Carcinoma in the paediatric patient: a literature review

L Tettamanti,A Caprioglio,S Tecco,G Barello,A Macchi,A Tagliabue,L Levrini

Abstract:Aim: Paediatric Oral Squamous Cell Carcinoma (OSCC) is rare, but its incidence is increasing, bringing forward the issue of the common pathogenic factors. The aim of this study is to verify the actual incidence of oral carcinoma reported in paediatric patients up to the age of 15 by thoroughly reviewing the available literature. Setting this cut-off age has allowed us to emphasise possible risk factors other than those always associated with the onset of this neoplasia, which are not present in this age bracket yet. Methods: In the first stage of the research, generic key words concerning OSCC in childhood were entered into two search engines. In the second stage, terms related to predisposing diseases connected to childhood oral carcinoma and those initially found were searched. Results: The literature review consisted of 55 documented cases from 1894 to 2011, of which 15 were part of complete published case reports. Conclusion: Paediatric OSCC, though uncommon, is not rare. The review has strongly highlighted the need to carry out an objective, thorough and standardised examination of the child's oral cavity, especially when systemic predisposing diseases, such as Epidermolysis bullosa, Xeroderma pigmentosum, Juvenile papillomatosis and Fanconi's anaemia, are present.
Analysis of Characteristics and Survival of Primary Cutaneous Adenoid Cystic Carcinoma of the Head and Neck

Sara Behbahani,David W. Wassef,Roman Povolotskiy,Jessica Pinto,Nia Joseph,Boris Paskhover

DOI: https://doi.org/10.1177/0003489420936719

2020-06-21

Abstract:Background/Objectives: Primary cutaneous adenoid cystic carcinoma (PCACC) is a rare skin tumor. The head and neck (H&N) is the most common anatomical location. Due to limited published cases, its clinical course and management are not well understood. Methods: The National Cancer Database (NCDB) was queried for all cases of H&N PCACC diagnosed from 2004 to 2016. Kaplan–Meier (KM) and Cox proportional hazards models were used to determine clinicopathological and treatment factors associated with survival outcomes. Results: A total of 201 cases were analyzed. The average age of diagnosis was 57.7 years (± SD 15.8). There was a female predilection (57.7%; P < .05) with the most common primary site being the ear (58.2%). The average tumor size was 15.9 mm in diameter. The most common treatment was surgery alone (51.7%) with wide local excision being the common surgery performed (36.3%). 5-year and 10-year OS were 87.0% and 76.0%, respectively. A total of 65.8% of cases were localized (Stage I and II). KM analysis indicated that gender, age, insurance status, Charlson-Deyo Comobordity Score, and stage were significant predictors of OS ( P < .05). Cox proportional hazards analysis revealed that patients with both private (HR 0.11, 95%CI [0.019-0.670]; P = .02) and government (HR 0.12, 95%CI [0.019-0.972]; P = .03) health insurance had a significantly decreased hazard of death than patients who were uninsured. Increasing age was associated with an increased hazard of death (HR 1.06, 95%CI [1.016-1.110]; P = .01). Conclusion: This study represents the largest cohort of H&N PCACC studied to date and provides important clinicopathologic information for this rare tumor. Additionally, our results emphasize the importance of health insurance as an independent predictor of survival in PCACC.
Head and neck cancer: effective prevention in youth and predictive diagnostics for personalised treatment strategies according to biological differences

Andreas Dietz,Gunnar Wichmann

DOI: https://doi.org/10.1007/s13167-011-0082-1

2011-05-14

Abstract:This article focuses on squamous cell carcinomas of the larynx, pharynx and oral cavity which count nearly 90% of the head and neck squamous cell carcinomas (HNSCC). Individual susceptibility depends on an individually given genetic background and/or acquired conditions or factors elevating the risk of HNSCC including smoking, alcohol abuse, and improper oral hygiene. A key issue in HNSCC pathogenesis is their development within large preneoplastic fields of mucosal epithelium made up of genetically altered cells that are clonally related to the carcinoma. Other individual differences in development of HNSCC comprise infection with pathogenic microbes and oncogenic human papillomavirus (HPV) subtypes like HPV 16 (a strong risk factor mainly for oropharyngeal cancer). Interestingly, the presence of HPV 16 also goes in line with better outcome after therapy. Vaccination against HPV infection in children plays an increasing role in prevention strategies and probably also reduces the oncogenic risk for HNSCC.

medicine, research & experimental
[Triacsins, inhibitors of fatty acid activating enzyme].

H. Tomoda,S. Ōmura

1993-08-01

Abstract:
Nasopharyngeal adenocarcinoma: A population-based analysis

Edward C. Kuan,Jose E. Alonso,Armin Arshi,Maie A. St. John

DOI: https://doi.org/10.1016/j.amjoto.2017.01.028

IF: 2.873

2017-05-01

American Journal of Otolaryngology

Abstract:OBJECTIVES/HYPOTHESIS: To describe the incidence and determinants of survival of patients with nasopharyngeal adenocarcinoma between the years of 1973 to 2012 using the Surveillance, Epidemiology, and End Result (SEER) database.STUDY DESIGN: Retrospective cohort study using a national database.METHODS: The SEER registry was utilized to calculate survival trends for patients with nasopharyngeal adenocarcinoma between 1973 and 2012. Patient data was then analyzed with respect to histopathology, age, sex, race, stage, grade, and treatment modalities (surgery and radiation therapy). Overall (OS) and disease-specific survival (DSS) were calculated.RESULTS: A total of 148 cases of nasopharyngeal adenocarcinoma were identified. The cohort was composed of 54.7% males. The mean age at diagnosis was 59.0years. The median OS was 60.6months. 59.4% of cases were treated with surgery, while 64.1% received radiation therapy. OS at 2, 5, and 10years was 63%, 49%, and 36%, respectively. There was no significant difference in OS and DSS between adenocarcinoma of the nasopharynx versus the sinonasal tract (p>0.05). On univariate analysis, younger age, surgery, surgery and radiation, and lower tumor grade were associated with improved OS and DSS, while papillary subtype, lower stage, and no distant metastasis were associated with improved OS alone (all p<0.05).CONCLUSIONS: Nasopharyngeal adenocarcinoma is an extremely rare malignancy with poor prognosis, with the exception of the papillary subtype. Age, grade, and surgical therapy are predictors of survival.

otorhinolaryngology
Squamous Cell Carcinoma of the Tongue in Young Patients: A Case Series and Literature Review

David L Best,Wyatt Spresser,Paul Shivers,Sean P Edwards,Brent B Ward

DOI: https://doi.org/10.1016/j.joms.2020.12.018

Abstract:Purpose: The purpose of this study was to describe 3 cases of tongue cancer in patients less than 21 years of age. Secondarily, a literature review was performed to examine disease presentation, risk factors, prognosis, and treatment strategies for young persons with tongue cancer. Methods: The authors presented 3 cases of childhood tongue cancer between 2009 and 2020 at the University of Michigan Department of Oral and Maxillofacial Surgery (Ann Arbor, MI). An electronic literature review was conducted via PubMed, Embase, Web of Science, and MLibrary. Results: Including the present case series, 64 studies reporting 108 cases were identified. Age at presentation ranged from newborn to 20 years, with a mean age of 14.5 years. The majority of patients were female (52.2%); 68.1% of patients presented with T1 or T2 disease. Nodal metastases were seen in 56.1% of patients. The most commonly identified predisposing factors included Fanconi anemia (13.9%), bone marrow transplant (9.3%), tobacco use (6.5%), and xeroderma pigmentosum (4.6%). Most patients received surgery alone (37.5%), followed by surgery with adjuvant radiation (33.8%); 60.6% underwent neck dissection. Overall survival was 60.3% at 1 year and 43.6% at 5 years. Conclusions: Oral tongue cancer in the young is a rare disease with poorly understood etiology. There is a need for oncologists and maxillofacial surgeons to collaborate in the study of genetic, social, environmental, and medical risk factors contributing to the disease. All patients should undergo high-throughput genetic sequencing to expand our understanding of the disease process and allow for targeted treatment strategies.
The epidemiology and current treatment of pediatric choroid plexus carcinoma: An analysis of the national cancer database.

Xinxin Wu,Michelle Swedek,Julia Griffin,Timothy Dean Malouff,Peter T. Silberstein

DOI: https://doi.org/10.1200/jco.2022.40.16_suppl.e14024

IF: 45.3

2022-06-01

Journal of Clinical Oncology

Abstract:e14024 Background: Choroid Plexus Carcinoma (CPC), a subtype of choroid plexus tumors (CPT), is a rare central nervous system neoplasm mostly affecting the pediatric population. The epidemiology of CPC is poorly understood due to the rarity of the disease. By analyzing the National Cancer Database (NCDB), we describe the demographic and social factors that influence the risk and current treatment of the cancer. Methods: We conducted a retrospective cohort analysis utilizing the 2018 National Cancer Database (NCDB) and included patients with Choroid Plexus Carcinoma with a histology-confirmed WHO grade III tumor, between ages 0-99 years (N = 202). Analysis was completed for the frequency of cases, types of treatment received, and overall survival within the pediatric population (age < 18 years, N = 139) and the adult population. Demographic factors were analyzed using Pearson Chi-squared tests, and survival was estimated using Kaplan-Meier curves. Results: The majority of the cases analyzed were white (55.4%), male (54%), and pediatric patients (66.8%, mean age at diagnosis = 15.17 years) with an average Charlson-Deyo Score of 0.24. The mean age at diagnosis of the pediatric population was 2.34 years (min = less than 1 years old/diagnosed in utero, max = 16, std. deviation = 3.84) while the mean age at diagnosis of the adult population was 43.49 years (min = 18, max = 84, std. deviation = 18.23.) The most common primary site for CPC was malignant neoplasm of the cerebral ventricle (87.6%) followed by malignant neoplasm of the brain stem (5.9%). Surgical procedure of the primary site was performed in 92.6% of cases including local excision, subtotal resection, resection, radical resection, partial resection of a lobe of brain, lobectomy, and surgery NOS. Radiation was not used 71.3% of the time, but was more than three times as likely to be used in the adult population after surgery than in the pediatric population after surgery (44.4% vs 14.4%, p value < 0.001). Most patients received chemotherapy (53%) with the administration of chemotherapy higher in the cohort less than 18 years old (69.8% versus 15.9%, p value < 0.001). Multiagent chemotherapy was administered as the first course of therapy as the top chemotherapeutic choice (86%) especially among the pediatric population (88.6%) compared to the adult population (60%) Palliative care was not provided in any of the cases. There was no statistical significance difference between the general survival of CPC between the pediatric and adult population. Conclusions: Historically, CPC is known as a pediatric cancer, but this NCDB study suggests that the frequency of the adult population affected is not negligible (31.2%). There is a difference regarding the current treatment of CPC in the pediatric versus adult population. Further study is needed to determine the impact of treatment and the importance of socioeconomic factors on the survival of CPC.

oncology
Clinical Manifestations of Hypopharynx Squamous Cell Carcinoma and Treatment Outcomes According to Age at Diagnosis.

Yujiao Li,Chaosu Hu

DOI: https://doi.org/10.1111/ijcp.14059

IF: 2.6

2021-01-01

International Journal of Clinical Practice

Abstract:Background The objective of this study is to assess the clinical manifestations and prognostic value of age on overall survival (OS) and cancer-specific survival (CSS) for hypopharynx squamous cell carcinoma (SCC) using the Surveillance, Epidemiology and End Results (SEER) database. Methods Patients with hypopharynx SCC were extracted from the SEER database between 2004 and 2014. We examined the clinicopathological variables using Chi-squared tests and we evaluated the association between survival and different variables, including age, race, grade, tumour location, T category, N category and surgery therapies to the primary tumour, using the methods of Kaplan-Meier. Univariate and multivariate analyses were performed to determine the effects of each variable on survival. Results A total of 3702 patients were analysed. The patients aged 25-49 tended to be black and present withN3 and stage IV (P <.01). In multivariate analyses, the patients aged 25-39 had better survival rates, and the risk of death became higher with increasing age. Compared with patients aged 25 to 39 years, the hazard ratios for patients aged 40-49, 50-59, 60-69, 70-79 and 80-95 years were 1.190 (95% confidence interval [CI] 0.584-2.423), 1.156 (95% CI 0.575-2.324), 1.315 (95% CI 0.654-2.642), 1.780 (95% CI 0.884-3.584) and 2.614 (95% CI 1.292-5.288) respectively. Subgroups analysis shows that the effect of advancing age was significantly associated with a higher risk of poor survival in patients who harboured moderately/poorly differentiated (all P <.05), T1-T4a, N0-N2b or stage I-IVa disease (all P <.05, respectively). Conclusion Younger patients tended to present with advanced N classification. Increasing age at diagnosis was associated with a significantly higher risk of poorer OS. However, when considering patients affected by more aggressive disease, age was not significantly associated with higher risk of dying from hypopharynx SCC. In high-risk patients, tumour characteristics rather than age should be considered when making treatment decisions.
The antiquity of Galley Hill man.

M. Ashley Montagu,K. Oakley

DOI: https://doi.org/10.1002/AJPA.1330070305

1949-09-01

American Journal of Physical Anthropology

Abstract:
Surgical management of rare tumors (Part 1)

Alyssa Stetson,Saurabh Saluja,Danielle B. Cameron,Sara A. Mansfield,Stephanie F. Polites,Joshua N. Honeyman,John P. Dahl,Mary T. Austin,Jennifer H. Aldrink,Emily R. Christison‐Lagay

DOI: https://doi.org/10.1002/pbc.31287

2024-08-28

Pediatric Blood & Cancer

Abstract:With an annual cumulative occurrence of approximately 15,000 in North America, all childhood cancers are rare. Very rare cancers as defined by both the European Cooperative Study Group for Rare Pediatric Cancers and the Children's Oncology Group fall into two principal categories: those so uncommon (fewer than 2 cases/million) that their study is challenging even through cooperative group efforts (e.g., pleuropulmonary blastoma and desmoplastic small round cell tumor) and those that are far more common in adults and therefore rarely studied in children (e.g., thyroid, melanoma, and gastrointestinal stromal tumor). Treatment strategies for these latter tumors are typically based on adult guidelines, although the pediatric variants of these tumors may harbor different genetic signatures and demonstrate different behavior. If melanoma and differentiated thyroid cancer are excluded, other rare cancer types account for only 2% of the cancers in children aged 0 to 14. This article highlights several of the most common rare tumor types.

oncology,pediatrics,hematology
The Demographic and Clinical Characteristics, Prognostic Factors, and Survival Outcomes of Head and Neck Carcinosarcoma: A SEER Database Analysis

Wanting Hou,Ouying Yan,Hong Zhu

DOI: https://doi.org/10.3390/biomedicines12112556

IF: 4.757

2024-11-09

Biomedicines

Abstract:Background: Head and neck carcinosarcoma (HNCS) is a rare and highly aggressive malignancy with limited research, resulting in an incomplete understanding of disease progression and a lack of reliable prognostic tools. This study aimed to retrospectively analyze the clinical characteristics and outcomes of HNCS patients using data from the Surveillance, Epidemiology, and End Results (SEER) database and to develop a nomogram to predict overall survival (OS) and cancer-specific survival (CSS). Methods: Patients diagnosed with HNCS from 1975 to 2020 were identified in the SEER database. Univariate and multivariate Cox regression analyses were conducted to identify independent prognostic indicators, with the optimal model selected using the minimal Akaike Information Criterion (AIC). The identified prognostic factors were incorporated into nomograms to predict OS and CSS. Model performance was assessed using the concordance index (C-index), area under the curve (AUC), calibration curves, and decision curve analysis (DCA). Survival curves were generated using Kaplan–Meier analysis and compared via the log-rank test. Results: A total of 152 HNCS patients were included, with 108 assigned to the training cohort and 44 to the validation cohort in a 7:3 ratio. Prognostic factors including age, primary tumor site, marital status, radiotherapy, chemotherapy, tumor size, pathological grade, and tumor stage were incorporated into the nomogram models. The models demonstrated strong predictive performance, with C-index values for OS and CSS of 0.757 and 0.779 in the training group, and 0.777 and 0.776 in the validation group, respectively. AUC values for predicting 3-, 5-, and 10-year OS were 0.662, 0.713, and 0.761, and for CSS the values were 0.726, 0.703, and 0.693. Kaplan–Meier analysis indicated significantly improved survival for patients with lower risk scores. The 3-, 5-, and 10-year OS rates for the entire cohort were 54.1%, 45.6%, and 35.1%, respectively, and the CSS rates were 62.9%, 57.5%, and 52.2%, respectively. Conclusions: This study provides validated nomograms for predicting OS and CSS in HNCS patients, offering a reliable tool to support clinical decision-making for this challenging malignancy. These nomograms enhance the ability to predict patient prognosis and personalize treatment strategies.

biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy
Treatment patterns and clinical outcomes of newly diagnosed locally advanced head and neck squamous cell carcinoma (LA HNSCC): A retrospective cohort analysis of national real-world data in England.

Chris M. Black,Anthony Kong,Gavin Chiu,John Bolodeoku,Olivia Massey,Amisha Patel,Alexander Ford,Tim Holbrook

DOI: https://doi.org/10.1200/jco.2023.41.16_suppl.e18075

IF: 45.3

2023-06-01

Journal of Clinical Oncology

Abstract:e18075 Background: LA HNSCC (stage III-IVb) is a potentially curable disease. However, many patients experience recurrence and metastasis, resulting in poorer prognoses. The multimodal approach to treating LA HNSCC makes the evaluation of treatment regimens difficult. This study aimed to describe the real-world treatment patterns, clinical outcomes and HCRU of LA HNSCC patients in England. Methods: This retrospective cohort study involved the use of data from the National Cancer Registration and Analysis Service databases (Cancer Registry, Systemic Anti-Cancer Therapy, Hospital Episode Statistics [HES], National Radiotherapy Dataset and Diagnostic Imaging Dataset). Adults with a first record of primary LA HNSCC between 01/01/2015 and 31/12/2018 were indexed. Treatment pathways and clinical outcomes were investigated over a maximum of 5-years follow-up period extending to 31 st December 2020. Results: 12,790 patients were included within the cohort. 52.1% (n = 6,665) received chemotherapy at some point during follow-up as part of their combination treatment with surgery and/or radiotherapy. Within the chemotherapy receiving cohort, 21.2% (n = 1,413) received induction chemotherapy prior to surgery or radiotherapy, 92.2% (n = 6,145) received concurrent chemo-radiotherapy and 11.8% (n = 787) received chemotherapy following surgery or radiotherapy, suggesting palliative treatment. The majority of chemotherapy regimens used were platinum-based. Of those receiving surgery (n = 5,292), the most common type of surgery was transoral surgery, occurring in 51.3% of the resectable patients. 40.2% of the overall cohort received salvage surgery during follow-up. 50.1% and 12.4% of patients experienced locoregional or distant metastatic progression, respectively and 39.2% of the cohort died. The 5-year overall survival (OS) was ~59% and ~55% for resected and unresected patients respectively. For event free survival (EFS), the 5-year median survival time post event free state index for the overall cohort was 12.32 months. Median survival time for the different tumour sites ranged from 19.4 and 2.6 months, with the nasopharynx and ‘other’ site group representing these range ends respectively. The highest HCRU/costs were incurred within the first 3 months following diagnosis; mean number of HNSCC-related inpatient stays were 2.93 (SD = 4.05), costing a total of £57,781,497 (per patient: £4,855.18 [£5872.05], mean[SD]). Conclusions: This is the first real world study using the UK NCRAS datasets to assess the treatment pathway and outcomes of the LA HNSCC population in England. Survival outcomes varied across site of primary tumour and patients diagnosed at stage 4 experienced poorer outcomes, highlighting the need for improved treatment plans and clinical outcomes for this patient population.

oncology

Sociocultural issues in clinical research: unraveling the Tuskegee syphilis study.

Infections in VLBW infants: studies from the NICHD Neonatal Research Network.

Clinical and Pathological Features of Head and Neck Follicular Dendritic Cell Sarcoma.

Pediatric Sporadic Burkitt Lymphoma of the Head and Neck: A Case Series and Analysis of National Trends

Head and neck carcinoma in children: A clinicopathological study of 42 cases

Pediatric mandibular malignancies: a comprehensive analysis of SEER data

Epidemiology, Risk Factors, and Prevention of Head and Neck Squamous Cell Carcinoma

Retrospective analysis of clinical features and prognosis of nasopharyngeal carcinoma in children and adolescents

Squamous cell carcinoma of the head and neck with unknown primary: trends and outcomes from a hospital-based registry

Oral Squamous Cell Carcinoma in the paediatric patient: a literature review

Analysis of Characteristics and Survival of Primary Cutaneous Adenoid Cystic Carcinoma of the Head and Neck

Head and neck cancer: effective prevention in youth and predictive diagnostics for personalised treatment strategies according to biological differences

[Triacsins, inhibitors of fatty acid activating enzyme].

Nasopharyngeal adenocarcinoma: A population-based analysis

Squamous Cell Carcinoma of the Tongue in Young Patients: A Case Series and Literature Review

The epidemiology and current treatment of pediatric choroid plexus carcinoma: An analysis of the national cancer database.

Clinical Manifestations of Hypopharynx Squamous Cell Carcinoma and Treatment Outcomes According to Age at Diagnosis.

The antiquity of Galley Hill man.

Surgical management of rare tumors (Part 1)

The Demographic and Clinical Characteristics, Prognostic Factors, and Survival Outcomes of Head and Neck Carcinosarcoma: A SEER Database Analysis

Treatment patterns and clinical outcomes of newly diagnosed locally advanced head and neck squamous cell carcinoma (LA HNSCC): A retrospective cohort analysis of national real-world data in England.